Carly Kabelac

455 total citations
5 papers, 226 citations indexed

About

Carly Kabelac is a scholar working on Infectious Diseases, Molecular Biology and Health. According to data from OpenAlex, Carly Kabelac has authored 5 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 1 paper in Molecular Biology and 1 paper in Health. Recurrent topics in Carly Kabelac's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (2 papers). Carly Kabelac is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (2 papers). Carly Kabelac collaborates with scholars based in United States. Carly Kabelac's co-authors include Raymond A. Harvey, Jeremy A. Rassen, William A. Meyer, Harvey W. Kaufman, Kathy A. Cronin, Lynne Penberthy, Steve Anderson, Norman E. Sharpless, Douglas R. Lowy and Valentina I. Petkov and has published in prestigious journals such as PLoS ONE, JAMA Internal Medicine and Journal of Biomedical Materials Research Part A.

In The Last Decade

Carly Kabelac

5 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carly Kabelac United States	5	183	42	38	22	21	5	226
Nina L. Reiser United States	8	171 0.9×	36 0.9×	21 0.6×	17 0.8×	25 1.2×	14	242
Jim Yee United States	8	194 1.1×	29 0.7×	23 0.6×	10 0.5×	31 1.5×	8	236
Elizaveta Kalaidina United States	2	267 1.5×	51 1.2×	34 0.9×	7 0.3×	50 2.4×	4	309
Alem Haile United States	2	266 1.5×	51 1.2×	34 0.9×	7 0.3×	50 2.4×	2	316
Sophia T. Tan United States	7	142 0.8×	50 1.2×	50 1.3×	22 1.0×	12 0.6×	16	273
Isabelle Arm‐Vernez Switzerland	6	240 1.3×	22 0.5×	12 0.3×	26 1.2×	28 1.3×	8	259
Ashley Sukhu United States	5	146 0.8×	21 0.5×	25 0.7×	6 0.3×	21 1.0×	10	182
Jessica Cambric United States	4	142 0.8×	19 0.5×	18 0.5×	6 0.3×	28 1.3×	4	175
Sophie Rand United States	6	159 0.9×	20 0.5×	19 0.5×	6 0.3×	23 1.1×	12	195
Jérémy Campos Switzerland	4	181 1.0×	34 0.8×	11 0.3×	18 0.8×	23 1.1×	5	281

Countries citing papers authored by Carly Kabelac

Since Specialization

Citations

This map shows the geographic impact of Carly Kabelac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carly Kabelac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carly Kabelac more than expected).

Fields of papers citing papers by Carly Kabelac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carly Kabelac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carly Kabelac. The network helps show where Carly Kabelac may publish in the future.

Co-authorship network of co-authors of Carly Kabelac

This figure shows the co-authorship network connecting the top 25 collaborators of Carly Kabelac. A scholar is included among the top collaborators of Carly Kabelac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carly Kabelac. Carly Kabelac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kaufman, Harvey W., Stanley Letovsky, William A. Meyer, et al.. (2023). SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes. Frontiers in Public Health. 11. 1193246–1193246. 4 indexed citations

2.

Kaufman, Harvey W., William A. Meyer, Oren J. Cohen, et al.. (2023). Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data. PLoS ONE. 18(3). e0280584–e0280584. 5 indexed citations

3.

Polinski, Jennifer M., Andrew R. Weckstein, Michael Batech, et al.. (2022). Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge. JAMA Network Open. 5(3). e222959–e222959. 37 indexed citations

4.

Munarin, Fabiola, Carly Kabelac, & Kareen L. K. Coulombe. (2021). Heparin‐modified alginate microspheres enhance neovessel formation in hiPSC ‐derived endothelial cells and heterocellular in vitro models by controlled release of vascular endothelial growth factor. Journal of Biomedical Materials Research Part A. 109(9). 1726–1736. 21 indexed citations

5.

Harvey, Raymond A., Jeremy A. Rassen, Carly Kabelac, et al.. (2021). Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection. JAMA Internal Medicine. 181(5). 672–672. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact